QDEL - Quidel Corporation
| Previous Close | 55.43 |
| Open | 55.49 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 54.00 - 55.49 |
| 52 Week Range | 23.28 - 57.30 |
| Volume | 430,230 |
| Avg. Volume | 359,845 |
| Market Cap | 2.054B |
| Beta | 1.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.24 |
| Earnings Date | May 8, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60.29 |
- Business Wire•yesterday
Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018
Quidel Corporation (QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2018 financial results after market close on Tuesday, May 8, 2018. Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions.
- GlobeNewswire•7 days ago
New Research Coverage Highlights Quidel, Eros International, Hennessy Capital Acquisition Corp. II, United Dominion Realty Trust, Fidus Investment, and Kadant — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, April 18, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Zacks•19 days ago
Is the Options Market Predicting a Spike in Quidel (QDEL) Stock?
Investors in Quidel (QDEL) need to pay close attention to the stock based on moves in the options market lately.
- GlobeNewswire•27 days ago
New Research Coverage Highlights Digital Realty Trust, United Dominion Realty Trust, Quidel, Brandywine Realty Trust, Beneficial, and Coca-Cola Bottling Co. Consolidated — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Business Wire•28 days ago
Quidel to Host 2018 Analyst and Investor Day in Chicago
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will host its 2018 Quidel Analyst and Investor Day at the Hyatt Regency O’Hare hotel in Chicago, Illinois on Tuesday, April 3, 2018.
- Zacks•last month
Implied Volatility Surging for Quidel (QDEL) Stock Options
Quidel (QDEL) needs investors to pay close attention to the stock based on moves in the options market lately.
- Business Wire•2 months ago
Quidel Announces Private Exchange Transactions
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 3.25% Convertible Senior Notes due 2020 .
- Benzinga•2 months ago
Near-Term Catalysts, Long-Term Opportunities Make Quidel A Strong Buy, Says Raymond James
Diagnostic healthcare products manufacturer Quidel Corporation (NASDAQ: QDEL )'s shares are not fully reflecting the company's growth potential and likely positive estimate revision bias, according to ...
- Benzinga•2 months ago
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! H & R Block Inc (NYSE: HRB ) stock gained more than ...
- Business Wire•2 months ago
Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510 clearance from the United States Food and Drug Administration to market its Sofia Lyme FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to ...
- Business Wire•2 months ago
Quidel to Present at Upcoming Conferences
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will p
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of QDEL earnings conference call or presentation 21-Feb-18 10:00pm GMT
Q4 2017 Quidel Corp Earnings Call
- Associated Press•2 months ago
Quidel reports 4Q loss
The San Diego-based company said it had a loss of 15 cents per share. Losses, adjusted for pretax expenses, were 11 cents per share. The medical diagnostics company posted revenue of $114.9 million in ...
- Business Wire•2 months ago
Quidel Reports Fourth Quarter and Full Year 2017 Financial Results
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ended December 31, 2017.
- Business Wire•2 months ago
Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510 clearance from the United States Food and Drug Administration for Quidel’s CLIA Waived QuickVue® Influenza A+B assay for the rapid, differential detection of influenza types A and B.
- Zacks•2 months ago
Options Traders Expect Huge Moves in Quidel (QDEL) Stock
Surging implied volatility makes Quidel (QDEL) stock lucrative to the option traders.
- Business Wire•2 months ago
Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fourth quarter and full year 2017 financial results after market close on Wednesday, February 21, 2018.
- GlobeNewswire•3 months ago
Report: Developing Opportunities within Quidel, Earthstone Energy, Potbelly, Chemed, Great Southern, and Intel — Future Expectations, Projections Moving into 2018
NEW YORK, Jan. 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quidel ...
- Zacks•3 months ago
Implied Volatility Surging for Quidel (QDEL) Stock Options
Investors in Quidel (QDEL) need to pay close attention to the stock based on moves in the options market lately.
- Business Wire•4 months ago
Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has completed the sale leaseback transaction for the Alere San Diego property on Summers Ridge Road that was acquired as part of the Triage Business from Alere, Inc.
- Business Wire•4 months ago
Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Strep A+ Assay
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received 510 clearance and Clinical Laboratory Improvements Amendments waiver from the United States Food and Drug Administration for its Sofia Strep A+ Fluorescent Immunoassay to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for ...
- Business Wire•4 months ago
Quidel Receives FDA Clearance for Its New Solana® Molecular Assay for the Detection of Group B Streptococcal Infections
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today it has received 510 clearance from the United States Food and Drug Administration for its Solana® GBS Assay for the direct, qualitative detection of Group B Streptococcus from enriched broth cultures of specimens from antepartum women.
- Business Wire•4 months ago
Quidel to Present at 36th Annual J.P. Morgan Healthcare Conference
Quidel Corporation , a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 36th Annual J.P.
- Business Wire•4 months ago
Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today filed the Company’s required report on Form 8-K/A with the Securities and Exchange Commission after market close.
